Skip To Main Content
Shengying Ye on Muck Rack

Shengying Ye

As seen in: Molecular Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shengying

Contact Shengying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nanotechnology-leveraged CRISPR/Cas systems: icebreaking in trace cancer-related nucleic acids biosensing - Molecular Cancer

|
By Weipan Peng, Mengting Shi, Bin Hu, Jingyu Jia, Xinyue Li, Nan Wang, Shuli Man, Long Ma, Shengying Ye
| Molecular Cancer Verified
Cancer is the leading cause of death worldwide. The World Health Organization (WHO) reports that cancer is responsible for nearly 10 million deaths annually, making up one-sixth of all deaths [1]. It is reported that most cancers are asymptomatic in the early stages, and 50% of them still only detected at an advanced stage [2], which seriously endanger human life and health. Thus, it is imperative to achieve their early detection [3]. As shown in Fig.
Open in Who Shared Issue with article?
See all 1 articles